Literature DB >> 1867192

Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes.

R G Roberts1, T F Barby, E Manners, M Bobrow, D R Bentley.   

Abstract

Using 10 overlapping nested sets of primers and using peripheral blood lymphocyte (PBL) total RNA as template, we have developed a system, based on PCR, which allows the rapid production of double-stranded cDNA corresponding to the entire coding sequence of the dystrophin gene. The product can be visualized on native minigels by ethidium staining and directly sequenced after gel purification. We have used this system to analyze the structures of PBL dystrophin mRNA in 26 Duchenne, Becker, or intermediate muscular dystrophy patients who have gross rearrangements of the dystrophin gene. In each case, the effect that the genomic rearrangement has on the structure of the transcript--and, by inference, on the dystrophin protein--has been determined, and the results confirm the frameshift hypothesis. The study also identifies a series of alternatively spliced transcripts which are specific to the rearranged genotypes and which seem therefore to arise following the alteration in the context of the splice signal. The system has been used for unambiguous identification of carrier females. Furthermore, the rapid production of microgram quantities of dystrophin cDNA from a readily accessible tissue makes point-mutation screening a practical proposition.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1867192      PMCID: PMC1683309     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  25 in total

1.  Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes.

Authors:  V C Sheffield; D R Cox; L S Lerman; R M Myers
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Direct diagnosis of carriers of Duchenne and Becker muscular dystrophy by amplification of lymphocyte RNA.

Authors:  R G Roberts; D R Bentley; T F Barby; E Manners; M Bobrow
Journal:  Lancet       Date:  1990 Dec 22-29       Impact factor: 79.321

3.  Becker muscular dystrophy: correlation of deletion type with clinical severity.

Authors:  A M Norman; N S Thomas; H M Kingston; P S Harper
Journal:  J Med Genet       Date:  1990-04       Impact factor: 6.318

4.  Illegitimate transcription: transcription of any gene in any cell type.

Authors:  J Chelly; J P Concordet; J C Kaplan; A Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

Review 6.  The Duchenne dystrophy story: from phenotype to gene and potential treatment.

Authors:  V Dubowitz
Journal:  J Child Neurol       Date:  1989-10       Impact factor: 1.987

7.  Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy.

Authors:  S Hodgson; K Hart; S Abbs; J Heckmatt; E Rodillo; M Bobrow; V Dubowitz
Journal:  J Med Genet       Date:  1989-11       Impact factor: 6.318

8.  Detection of a novel point mutation causing haemophilia A by PCR/direct sequencing of ectopically-transcribed factor VIII mRNA.

Authors:  L P Berg; K Wieland; D S Millar; M Schlösser; M Wagner; V V Kakkar; J Reiss; D N Cooper
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

9.  Detection of three novel mutations in two haemophilia A patients by rapid screening of whole essential region of factor VIII gene.

Authors:  J A Naylor; P M Green; A J Montandon; C R Rizza; F Giannelli
Journal:  Lancet       Date:  1991-03-16       Impact factor: 79.321

10.  Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene.

Authors:  E F Gillard; J S Chamberlain; E G Murphy; C L Duff; B Smith; A H Burghes; M W Thompson; J Sutherland; I Oss; S E Bodrug
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

View more
  40 in total

1.  RNA analysis from newborn screening dried blood specimens.

Authors:  Y H Zhang; E R McCabe
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

Review 2.  Genetic and clinical correlations of Xp21 muscular dystrophy.

Authors:  K M Bushby
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  An intact cysteine-rich domain is required for dystrophin function.

Authors:  R D Bies; C T Caskey; R Fenwick
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

4.  Identification of seven novel cryptic exons embedded in the dystrophin gene and characterization of 14 cryptic dystrophin exons.

Authors:  Zhujun Zhang; Yasuaki Habara; Atsushi Nishiyama; Yoshinobu Oyazato; Mariko Yagi; Yasuhiro Takeshima; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2007-06-20       Impact factor: 3.172

5.  Neuronal SH-SY5Y cells use the C-dystrophin promoter coupled with exon 78 skipping and display multiple patterns of alternative splicing including two intronic insertion events.

Authors:  Atsushi Nishida; Maki Minegishi; Atsuko Takeuchi; Hiroyuki Awano; Emma Tabe Eko Niba; Masafumi Matsuo
Journal:  Hum Genet       Date:  2015-07-08       Impact factor: 4.132

6.  Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis.

Authors:  S C Yau; M Bobrow; C G Mathew; S J Abbs
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

7.  Point mutations in the dystrophin gene.

Authors:  R G Roberts; M Bobrow; D R Bentley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

8.  Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy.

Authors:  T M Nguyen; G E Morris
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

9.  Functional significance of dystrophin positive fibres in Duchenne muscular dystrophy.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin
Journal:  Arch Dis Child       Date:  1993-05       Impact factor: 3.791

10.  Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort.

Authors:  Kevin M Flanigan; Diane M Dunn; Andrew von Niederhausern; Payam Soltanzadeh; Eduard Gappmaier; Michael T Howard; Jacinda B Sampson; Jerry R Mendell; Cheryl Wall; Wendy M King; Alan Pestronk; Julaine M Florence; Anne M Connolly; Katherine D Mathews; Carrie M Stephan; Karla S Laubenthal; Brenda L Wong; Paula J Morehart; Amy Meyer; Richard S Finkel; Carsten G Bonnemann; Livija Medne; John W Day; Joline C Dalton; Marcia K Margolis; Veronica J Hinton; Robert B Weiss
Journal:  Hum Mutat       Date:  2009-12       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.